WealthCare Investment Partners LLC Decreases Stock Holdings in CVS Health Co. (NYSE:CVS)

WealthCare Investment Partners LLC reduced its position in shares of CVS Health Co. (NYSE:CVS) by 5.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,987 shares of the pharmacy operator’s stock after selling 333 shares during the period. WealthCare Investment Partners LLC’s holdings in CVS Health were worth $477,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Atticus Wealth Management LLC lifted its position in CVS Health by 149.0% in the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 219 shares during the last quarter. USA Financial Formulas lifted its holdings in shares of CVS Health by 573.2% in the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 321 shares during the last quarter. Ables Iannone Moore & Associates Inc. acquired a new stake in shares of CVS Health in the 4th quarter valued at about $32,000. Creekmur Asset Management LLC purchased a new position in CVS Health during the 4th quarter worth approximately $34,000. Finally, Steph & Co. increased its position in CVS Health by 192.0% during the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 288 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on CVS. Cantor Fitzgerald restated a “neutral” rating and set a $58.00 target price on shares of CVS Health in a research report on Wednesday, June 12th. Baird R W upgraded shares of CVS Health to a “hold” rating in a research note on Thursday, May 30th. SVB Leerink reiterated a “market perform” rating and set a $60.00 price target (down previously from $87.00) on shares of CVS Health in a research note on Wednesday, May 1st. TD Cowen cut shares of CVS Health from a “buy” rating to a “hold” rating and decreased their price target for the stock from $99.00 to $59.00 in a research note on Tuesday, May 7th. Finally, Wells Fargo & Company decreased their price target on shares of CVS Health from $76.00 to $60.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 7th. Eleven investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $75.05.

Insider Activity at CVS Health

In other CVS Health news, Director Edward J. Ludwig acquired 1,000 shares of the company’s stock in a transaction dated Thursday, May 2nd. The stock was acquired at an average cost of $53.88 per share, with a total value of $53,880.00. Following the purchase, the director now directly owns 21,630 shares in the company, valued at approximately $1,165,424.40. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. 0.24% of the stock is owned by corporate insiders.

CVS Health Price Performance

Shares of NYSE:CVS traded down $2.65 during trading on Thursday, hitting $57.98. 3,867,656 shares of the stock were exchanged, compared to its average volume of 11,985,243. The company has a market cap of $72.79 billion, a PE ratio of 10.65, a P/E/G ratio of 0.58 and a beta of 0.53. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. The company has a fifty day moving average price of $60.16 and a two-hundred day moving average price of $70.45. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The firm had revenue of $88.44 billion for the quarter, compared to analysts’ expectations of $89.33 billion. During the same quarter in the previous year, the firm posted $2.20 earnings per share. The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. On average, analysts forecast that CVS Health Co. will post 7.02 EPS for the current year.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.